T-cell dependent immunoselection.

Oncoimmunology ·Vol. 1 ·No. 7 ·2012-00-01 ·Pages 1003

Andersen MH

Abstract

暂无摘要

MeSH Terms

Exome Humans Neoplasms T-Lymphocytes, Cytotoxic Whole Exome Sequencing

Authors & Affiliations

1 authors, click to expand affiliations / ORCID

Andersen Mads Hald

Department of Hematology; Center for Cancer Immune Therapy (CCIT); Copenhagen University Hospital Herlev; Herlev, Denmark.

References (7)

7 references, click to expand

Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting.
Nature. 2012 Feb 08;482(7385):400-4 PMID: 22318521
Vemurafenib: the road to personalized medicine in melanoma.
Drugs Today (Barc). 2012 Feb;48(2):109-18 PMID: 22384451
Expression of tumour-specific antigens underlies cancer immunoediting.
Nature. 2012 Feb 08;482(7385):405-9 PMID: 22318517
Human leukocyte antigen-A2-restricted CTL responses to mutated BRAF peptides in melanoma patients.
Cancer Res. 2006 Mar 15;66(6):3287-93 PMID: 16540682
Immunogenicity of constitutively active V599EBRaf.
Cancer Res. 2004 Aug 1;64(15):5456-60 PMID: 15289355
Naturally occurring T-cell response against mutated p21 ras oncoprotein in pancreatic cancer.
Clin Cancer Res. 2006 Feb 15;12(4):1365-72 PMID: 16489095
CD4(+) T-cell recognition of mutated B-RAF in melanoma patients harboring the V599E mutation.
Cancer Res. 2004 Mar 1;64(5):1595-9 PMID: 14996715

Article Info

Journal

Oncoimmunology

Abbr.

Oncoimmunology

ISSN

2162-4011

DOI

Published

2012-00-01

Pages

1003

Language

English

Region

United States

NLM ID

101570526

PMCID

PMC3494614

Corrections

CommentOn

PMID: 22318521

External Links

Analysis Services